Low dose versus medium dose UV-A1 treatment in severe atopic eczema.
DOI:
https://doi.org/10.2340/00015555754345Abstract
Twenty-two patients with severe atopic eczema were included in a therapy study with UV-A1 (wavelengths > 340 nm) treatment. The patients were divided into two dose groups, each consisting of 11 patients. One group received 10 J/cm2 and the other 50 J/cm2 five times a week for 3 consecutive weeks. No topical or systemical steroids or antihistamines were allowed. Using the SCORAD index as a measure of disease activity before onset of therapy and after 10 and 15 treatments, we observed a significant improvement in both dose groups after 15 treatments (10 J/cm2: p < 0.05, 50 J/cm2: p < 0.005). After 10 treatments only the improvement in the 50 J/cm2 group was significant (p < 0.005)Downloads
Download data is not yet available.
Downloads
Published
1995-01-01
How to Cite
Kowalzick, L., Kleinheinz, A., Weichenthal, M., Neuber, K., Köhler, I., Grosch, J., … Ring, J. (1995). Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Dermato-Venereologica, 75(1), 43–45. https://doi.org/10.2340/00015555754345
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
